Thomas Duflot - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Thomas Duflot

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Journal of Medicinal Chemistry|August 23, 2019

Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase DomainJan S Kramer, Stefano Woltersdorf, Thomas Duflot, et al.

Wellcome Open Research|June 10, 2021

Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working groupClaire C Austin, Alexander Bernier, Louise Bezuidenhout, et al.

Journal of Advanced Research|December 30, 2022

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injuryMatthieu Leuillier, Thomas Duflot, Séverine Ménoret, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Journal of Medicinal Chemistry|August 23, 2019

Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase DomainJan S Kramer, Stefano Woltersdorf, Thomas Duflot, et al.

Wellcome Open Research|June 10, 2021

Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working groupClaire C Austin, Alexander Bernier, Louise Bezuidenhout, et al.

Journal of Advanced Research|December 30, 2022

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injuryMatthieu Leuillier, Thomas Duflot, Séverine Ménoret, et al.

Pageof 5